Oral tablet containing 2-[(4-methoxy-3-methyl)-2-pyridyl]ethylsulfonyl-5-(1-H-pyrrole-1-group)-1H-benzimidazole

Oral tablet containing 2-[(4-methoxy-3-methyl)-2-pyridyl]ethylsulfonyl-5-(1-H-pyrrole-1-group)-1H-benzimidazole

  • CN 1,184,970 C
  • Filed: 01/24/2002
  • Issued: 01/19/2005
  • Est. Priority Date: 01/24/2002
  • Status: Active Grant
First Claim
Patent Images

1. stable oral tablet is characterized in that adopting following method preparation:

  • With active component 2-[(4-methoxyl group-3-methyl)-the 2-pyridine radicals] methylsulfinyl-5-(1H-pyrroles-1-yl)-1H-benzimidazole;

    mole dosage as stabilizing agent is 0.2~

    7.0 times a magnesium hydroxide of active component;

    with the medical additive mixing that is suitable for preparing nude film;

    with the mixture tablet forming that obtains;

    form material with thin film nude film is carried out the coating first time, and this tablet is carried out the coating second time with enteric-coating material.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×